Pluri Inc (PLUR)
5.36
-0.24
(-4.28%)
USD |
NASDAQ |
May 01, 16:00
5.36
0.00 (0.00%)
After-Hours: 20:00
Pluri Price to Book Value: 6.369 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 30, 2024 | 6.654 |
April 29, 2024 | 6.262 |
April 26, 2024 | 6.365 |
April 25, 2024 | 5.822 |
April 24, 2024 | 6.048 |
April 23, 2024 | 5.941 |
April 22, 2024 | 5.953 |
April 19, 2024 | 6.238 |
April 18, 2024 | 6.001 |
April 17, 2024 | 6.143 |
April 16, 2024 | 6.787 |
April 15, 2024 | 6.737 |
April 12, 2024 | 6.832 |
April 11, 2024 | 6.892 |
April 10, 2024 | 7.082 |
April 09, 2024 | 6.749 |
April 08, 2024 | 6.654 |
April 05, 2024 | 6.524 |
April 04, 2024 | 5.941 |
April 03, 2024 | 6.238 |
April 02, 2024 | 6.832 |
April 01, 2024 | 7.070 |
March 28, 2024 | 7.662 |
March 27, 2024 | 8.296 |
March 26, 2024 | 9.618 |
Date | Value |
---|---|
March 25, 2024 | 8.798 |
March 22, 2024 | 8.957 |
March 21, 2024 | 8.864 |
March 20, 2024 | 9.052 |
March 19, 2024 | 8.911 |
March 18, 2024 | 8.911 |
March 15, 2024 | 9.403 |
March 14, 2024 | 8.864 |
March 13, 2024 | 9.097 |
March 12, 2024 | 9.052 |
March 11, 2024 | 9.133 |
March 08, 2024 | 9.524 |
March 07, 2024 | 9.070 |
March 06, 2024 | 9.429 |
March 05, 2024 | 8.288 |
March 04, 2024 | 7.921 |
March 01, 2024 | 7.544 |
February 29, 2024 | 7.637 |
February 28, 2024 | 7.440 |
February 27, 2024 | 7.260 |
February 26, 2024 | 6.940 |
February 23, 2024 | 7.048 |
February 22, 2024 | 6.855 |
February 21, 2024 | 6.980 |
February 20, 2024 | 7.355 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7276
Minimum
Sep 26 2022
17.68
Maximum
May 14 2020
3.621
Average
2.355
Median
Oct 31 2023
Price to Book Value Benchmarks
InspireMD Inc | 1.152 |
Taro Pharmaceutical Industries Ltd | 0.8959 |
BiomX Inc | 7.968 |
Alpha Tau Medical Ltd | 2.016 |
Raphael Pharmaceutical Inc | 69.89 |
Price to Book Value Related Metrics
PS Ratio | 76.84 |
Price | 5.36 |
Earnings Yield | -86.57% |
Market Cap | 28.02M |